The 16th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2023) took place in the Swedish Exhibition & Congress Centre on 28 March-1 April.
Organised by PCO Kenes, the event offered the participants five days of presentations, workshops, and networking sessions.
4,120 leading scientists, clinicians, and industry representatives from around the world – 3,289 onsite and 831 online – came together to form new collaborations and discuss genetics, biomarkers, cutting-edge technologies, clinical trials, and therapeutics.
Professor Abraham Fisher, President of AD/PD, said: “The Conference has provided a unique platform for sharing new research findings and promoting collaborations among scientists and clinicians worldwide. We are confident that the insights and innovations presented at this Conference will accelerate progress towards finding effective treatments for Alzheimer’s and Parkinson’s diseases.”